Liver cirrhosis, a late stage of progressive hepatic fibrosis, is characterized by the distortion of the normal liver architecture and the development of regenerative nodules. This chronic liver disease is often associated with a wide range of complications that pose significant challenges to healthcare professionals.
Portal hypertension is a common complication of liver cirrhosis, leading to varices and ascites. Management includes the use of non-selective beta-blockers and endoscopic therapies to prevent variceal bleeding. Diuretics and sodium restriction are the mainstays of ascites management.
This neuropsychiatric syndrome is another major complication, characterized by personality changes, intellectual impairment, and a depressed level of consciousness. Treatment typically includes the reduction of ammonia production and absorption using lactulose or rifaximin.
Hepatorenal syndrome, a type of prerenal kidney injury, is a serious complication that requires timely diagnosis and management. Therapeutic strategies include volume expansion, use of vasoconstrictors, and, in severe cases, renal replacement therapy or liver transplantation.
Liver cirrhosis increases the risk of hepatocellular carcinoma. Regular surveillance using ultrasound, with or without alpha-fetoprotein measurement, is recommended. Treatment options include surgical resection, liver transplantation, and locoregional therapies.
Understanding and managing the complex complications of liver cirrhosis require a comprehensive and multidisciplinary approach. By recognizing these complications early and initiating appropriate treatment, healthcare professionals can significantly improve the prognosis and quality of life for patients with this chronic liver disease.
1.
The need for more Latinx participants in Alzheimer's trials is urgent.
2.
Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa
3.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
4.
In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?
5.
Study offers clearer picture of childhood brain tumor survival
1.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
2.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
3.
Comprehensive Standards in Oncology for Modern Medicine
4.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
5.
Practical Standards in Hematology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation